The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increasesin vitrodrug delivery across blood-brain barrier cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increasesin vitrodrug delivery across blood-brain barrier cells
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 167, Issue 7, Pages 1431-1447
Publisher
Wiley
Online
2012-07-13
DOI
10.1111/j.1476-5381.2012.02103.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS
- (2011) Robert W. Robey et al. Anti-Cancer Agents in Medicinal Chemistry
- Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy
- (2011) Sumitra Ananda et al. JOURNAL OF CLINICAL NEUROSCIENCE
- TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes
- (2011) Liangran Guo et al. JOURNAL OF CONTROLLED RELEASE
- Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier
- (2011) Stefanie Wohlfart et al. JOURNAL OF CONTROLLED RELEASE
- Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma
- (2011) Masashi Yanae et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Liposome-Encapsulated Doxorubicin Reverses Drug Resistance by Inhibiting P-Glycoprotein in Human Cancer Cells
- (2011) Chiara Riganti et al. MOLECULAR PHARMACEUTICS
- A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells
- (2010) Joanna Kopecka et al. JOURNAL OF CONTROLLED RELEASE
- Rapid, Reversible Modulation of Blood-Brain BarrierP-Glycoprotein Transport Activity by Vascular Endothelial Growth Factor
- (2010) B. T. Hawkins et al. JOURNAL OF NEUROSCIENCE
- ABC and SLC Transporter Expression and Pot Substrate Characterization across the Human CMEC/D3 Blood−Brain Barrier Cell Line
- (2010) Stephen M. Carl et al. MOLECULAR PHARMACEUTICS
- Regulation of the expression of inducible nitric oxide synthase
- (2010) Andrea Pautz et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Targeted Therapies for Malignant Glioma
- (2009) Ronald W. Mercer et al. BIODRUGS
- RNOP-09: Pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study
- (2009) Christoph P Beier et al. BMC CANCER
- P-Glycoprotein and Breast Cancer Resistance Protein Restrict Apical-to-Basolateral Permeability of Human Brain Endothelium to Amyloid-β
- (2009) Leon M Tai et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin
- (2008) Yumei Ye et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Multi-functional nanocarriers to overcome tumor drug resistance
- (2008) Lara S. Jabr-Milane et al. CANCER TREATMENT REVIEWS
- Medulloblastoma: From Molecular Pathology to Therapy
- (2008) A. Rossi et al. CLINICAL CANCER RESEARCH
- Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-κB ligand through modulation of NF-κB pathway
- (2008) Kwang Seok Ahn et al. INTERNATIONAL JOURNAL OF CANCER
- Lipopolysaccharide Impairs Blood–Brain Barrier P-glycoprotein Function in Mice Through Prostaglandin- and Nitric Oxide-Independent Pathways
- (2008) Mohamad A. Salkeni et al. Journal of Neuroimmune Pharmacology
- RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells
- (2008) S. Doublier et al. MOLECULAR CANCER RESEARCH
- Activation of Nuclear Factor- B Pathway by Simvastatin and RhoA Silencing Increases Doxorubicin Cytotoxicity in Human Colon Cancer HT29 Cells
- (2008) C. Riganti et al. MOLECULAR PHARMACOLOGY
- Prognostic significance of the immunohistochemical expression ofO6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas
- (2008) Takao Nakagawa et al. NEUROPATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now